The IPO Buzz: Beta Bionics (BBNX Proposed) Files Terms for $112.5 Million IPO

Beta Bionics (BBNX Proposed), the developer of the iLet Bionic Pancreas (iLet) – the first insulin delivery device approved by the FDA to use adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake – disclosed the terms for its $112.5 million IPO early today – Wednesday, Jan. […]

Read More